Donor cells tested to fight mysterious autoimmune disease
Disease control
Recruiting now
This early-stage study is testing a new cell therapy called ACE1831 for people with active IgG4-Related Disease (IgG4-RD), a condition where the immune system attacks the body's own tissues. The therapy uses immune cells (gamma delta T cells) from healthy donors. Researchers will…
Phase: PHASE1, PHASE2 • Sponsor: Acepodia Biotech, Inc. • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC